What if you'd held ABUS?
A $1,000 investment in Arbutus Biopharma Corporation (ABUS) at the month-end close of 2007-07 would be worth $928 at the close of 2026-09 — -7.2% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $7,635.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2007
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2007 | $1,000 | — |
| 2008 | $319 | -68.1% |
| 2009 | $1,011 | +217.2% |
| 2010 | $1,033 | +2.2% |
| 2011 | $330 | -68.1% |
| 2012 | $1,090 | +230.7% |
| 2013 | $1,752 | +60.7% |
| 2014 | $3,330 | +90.1% |
| 2015 | $978 | -70.6% |
| 2016 | $538 | -44.9% |
| 2017 | $1,110 | +106.1% |
| 2018 | $842 | -24.2% |
| 2019 | $611 | -27.4% |
| 2020 | $780 | +27.7% |
| 2021 | $855 | +9.6% |
| 2022 | $512 | -40.1% |
| 2023 | $549 | +7.3% |
| 2024 | $719 | +30.8% |
| 2025 | $1,057 | +47.1% |
| 2026 | $1,132 | +7.1% |
Best and worst month-end to buy
The best single month-end close to have bought ABUS was 2020-03 ($1.01): $1,000 then is $5,099 today. The worst was 2015-01 ($25.61): $1,000 then is $201.
FAQ
What would $1,000 in ABUS be worth today?
A $1,000 investment in Arbutus Biopharma Corporation (ABUS) at the start of 2007 would be worth about $928 today, a total return of -7.2%. Dividends are reinvested in these figures.
What were the best and worst years for ABUS?
Arbutus Biopharma Corporation (ABUS)'s strongest calendar year since 2007 was 2012, a +230.7% return — $1,000 held through that year became about $3,307 by year-end. Its weakest year was 2015, at -70.6%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in ABUS have grown?
Investing $100 at the end of every month since 2007-07 would have grown to about $34,041 on $23,100 invested.
Did ABUS beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $7,635. ABUS trailed the S&P 500 by +87.8% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Arbutus Biopharma Corporation (ABUS) historical total-return data from 2007-07 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.